See also this year's filing and all EDGAR filings for this company.
PDF Report 0001356576_2026_Supernus_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001356576, Supernus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 644,182,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 694,338,000 |
| 2 | PropertyPlantAndEquipmentNet | 10,531,000 |
| 3 | remainder_Assets | 103,597,000 |
| 4 | LiabilitiesCurrent | 338,171,000 |
| 5 | LiabilitiesNoncurrent | 52,557,000 |
| 6 | remainder_Liabilities | 206,000 |
| 7 | CostOfGoodsAndServicesSold | 75,120,348 |
| 8 | SellingGeneralAndAdministrativeExpense | 535,516,242 |
| 9 | ResearchAndDevelopmentExpense | 106,616,602 |
| 10 | remainder_Expenses | 103,625,684 |
| 11 | remainder_Revenues | 765,850,499 |
| 12 | remainder_NetIncome | 14,010,042 |
| 13 | remainder_ComprehensiveNetIncome | 75,362 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,452,648,000 |
| 1 | Liabilities | 390,934,000 |
| 2 | Expenses | 820,878,876 |
| 3 | Revenues | 765,850,499 |
| 4 | StockholdersEquity | 1,061,714,000 |
| 5 | NetIncome | -41,018,335 |
| 6 | ComprehensiveNetIncome | -40,980,654 |
| 7 | BaseVar | 1,722,198,390 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.47 |
| 9 | EconomicCapitalRatio | 3.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
